ABITEC Corporation improves solubility of topical and transdermal applications with functional lipid excipients
Columbus, OH – [May 30, 2019] - ABITEC Corporation continues to add new innovative ingredients that solve the everyday delivery challenges of the pharmaceutical market.
ABITEC Corporation, a global manufacturer of functional lipid excipients continues to pursue new technologies that solve various formulation challenges in the pharmaceutical market. The challenges associated with solubility and enhanced permeation of topical and transdermal applications continues to drive the need for lipid-based solutions.
ABITEC’s functional lipid excipients such as CAPMUL®, ACCONON®, and CAPTEX® are utilized in combination with one another to enhance the solubility and emulsification properties of topical and transdermal products. ABITEC’s excipients provide improved transdermal penetration of actives, increased active solubilization, and enhanced emulsification in creams and gels. ABITEC is dedicated to developing high quality ingredients for use globally in a range of diversified pharmaceutical applications.
ABITEC’s trademarked specialty lipids include Capmul, Captex, Caprol, Acconon, Sterotex, Nutri Sperse, Hydro~Kote, and Pureco. Product application areas vary from pharmaceutical, nutritional and cosmetic products, to the manufacturing of foams, creams, ointments and lotions. These ingredients are produced in the USA under cGMP manufacturing.
About ABITEC Corporation
ABITEC Corporation is part of ABF Ingredients and is headquartered in Columbus, Ohio, USA with two manufacturing sites in the Midwest. ABITEC specializes in the manufacturing and distribution of specialty lipid ingredients for use in the pharmaceutical, nutraceutical, and specialty chemical industries. In addition, ABITEC offers contract and toll manufacturing services for customers looking to develop and manufacture new oleochemical molecules, blends, or toll-manufacture of established products.
About ABF Ingredients
ABF Ingredients is a division of Associated British Foods that focuses on high value ingredients for both food and non-food areas and comprises a range of ingredient companies which include AB Enzymes, Ohly, PGP International, and SPI Pharma. The group has established strong market positions across a variety of industries, including cereal specialties, enzymes, esters, extruded ingredients, functional polyols, drug delivery systems, specialty lipids, specialty powders, specialty flours, and yeast extracts worldwide.
For further information, please contact:
Manager: Marketing Research and Communications
614-429-6453 | [email protected]
This press release includes "forward-looking statements" within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are subject to known and unknown risks and uncertainties, many of which may be beyond our control. We caution you that the forward-looking information presented in this press release is not a guarantee of future events, and that actual events may differ materially from those made in or suggested by the forward-looking information contained in this press release. In addition, forward-looking statements generally can be identified by the use of forward-looking terminology such as "may," "plan," "seek," "comfortable with," "will," "expect," "intend," "estimate," "anticipate," "believe" or "continue" or the negative thereof or variations thereon or similar terminology. Any forward-looking information presented herein is made only as of the date of this press release, and we do not undertake any obligation to update or revise any forward-looking information to reflect changes in assumptions, the occurrence of unanticipated events, or otherwise.